Dorzolamide: Development and clinical application of a topical carbonic anhydrase inhibitor

1997/09/01 by Norbert Pfeiffer · 9 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Acetazolamide #Anesthesia #Biochemistry #Carbonic anhydrase #Carbonic anhydrase inhibitor #Chemistry #Dorzolamide #Enzyme #Enzyme function and inhibition #Glaucoma and retinal disorders #Intraocular pressure #Medicine #Migraine and Headache Studies #Ophthalmology #Pharmacology #Side effect (computer science) #Timolol

paper · doi:10.1016/s0039-6257(97)00053-2

openalex publication_date 1997/09/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Significant Metabolic Acidosis Induced by Acetazolamide

Cited by

• VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. [europepmc]
• Soluble adenylyl cyclase in the eye. [europepmc]
• Anti-glaucoma potential of Heliotropium indicum Linn in experimentally-induced glaucoma. [europepmc]
• Role of cyclic AMP in the eye with glaucoma. [europepmc]
• Allergic contact dermatitis to dorzolamide and benzalkonium chloride. [europepmc]
• Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review. [europepmc]
• Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development. [europepmc]
• Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches. [europepmc]
• A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension. [europepmc]